GeneDx Holdings Corp. (WGS)
NasdaqGS · USD · Healthcare · Diagnostics & Research
$61.26 (+9.10%) as of
Key statistics
- Market cap
- 1.83B
- Forward P/E
- 51.11
- EPS (TTM)
- -3.63
- Dividend yield
- 0.00%
- 52-week range
- 32.21 – 170.87
- Beta
- 1.97
- Revenue (TTM)
- 454.43M
- Profit margin
- -23.41%
- Analyst target
- $93.50
- Volume
- 1.00M
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Stamford, CT, United States
- Employees
- 1,300
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.